A Phase 2 Multi-institutional Study to Evaluate Gemcitabine and Fractionated Stereotactic Radiotherapy for Unresectable, Locally Advanced Pancreatic Adenocarcinoma
Pract Radiat Oncol
.
2013 Apr-Jun;3(2 Suppl 1):S4-5.
doi: 10.1016/j.prro.2013.01.016.
Epub 2013 Mar 25.
Authors
A T Wild
1
,
D T Chang
2
,
K A Goodman
3
,
D A Laheru
1
,
L Zheng
1
,
S P Raman
1
,
L A Columbo
2
,
C L Wolfgang
1
,
A C Koong
2
,
J M Herman
1
Affiliations
1
Johns Hopkins University School of Medicine, Baltimore, MD.
2
Stanford University, Stanford, CA.
3
Memorial Sloan-Kettering Cancer Center, New York, NY.
PMID:
24674559
DOI:
10.1016/j.prro.2013.01.016
No abstract available